InvestorsHub Logo
Followers 13
Posts 865
Boards Moderated 0
Alias Born 02/17/2017

Re: misiu143 post# 33702

Wednesday, 01/16/2019 4:45:15 PM

Wednesday, January 16, 2019 4:45:15 PM

Post# of 233271
Got it. So although both drugs fall into a similar (and new) class of oncology drugs that work based on certain genetic markers, they have very different mechanisms of action. Sounds like leronlimab may be more complementary with Keytruda, as the CCR5 inhibitor would slow/halt metastasis while Keytruda allowed the immune system to attack the existing cancer cells.

And yeah... talk about side effects!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News